Concentration of Risk

BRISTOL MYERS SQUIBB CO

Medium

BMY · NYSE · Pharmaceutical Preparations · CIK 0000014272

Latest filing: 10-K · 2026-02-11

Customer concentration

Significant Customers note · revenue dependency

High
Top exposure
36%
Mckesson Corporation
Other major customers
Cencora29%
Cardinal Health Inc22%
Each is a separate customer disclosed individually — the figures are not sub-parts of the headline and may be measured against different revenue bases, so they are not additive.
+2.0pp YoY

Click a point to open the SEC source

FY23FY24FY250%9%18%27%36%

Geographic concentration

Segment reporting · geographic revenue

High
Top exposure
69.1%
United StatesNamed
-1.5pp YoY

Click a point to open the SEC source

FY23FY24FY250%20%40%60%80%

Supplier concentration

Risk Factors · supply chain dependency

Low
Dependency
Single source
Single sourceNamed
Qualitative disclosure — no % quantified (informational, not scored)
Flat
FY25

Qualitative dependency level by filing year.

Product concentration

ASC 275 · disclosed dependence on a specific product or service

Low
Top exposure
<10%
No disclosure detected
Flat

Credit concentration

ASC 825 · concentration of credit risk note

Low
Receivables
<10%
Diversified
Flat